I bought this stock because they were trying to develop a product called "Simplivir," an anti-herpes medicine. I guess that it never got off the ground. Then, there is of course, "SynDNA." It never made it to major production either.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.